Clinical Trials Logo

Clinical Trial Summary

Extracorporeal Shock Wave treatment is a well established treatment in orthopedics. Considerable success has been reported after treatment of various soft tissue pathologies (Tendinitis, heel spur etc). In recent years, encouraging results have been reported concerning the effect of the shock-wave on chronic wounds. It has been reported that healing time can be considerably shortened if shock-waves are applied to the wound in addition to conventional wound treatment. Yet, randomized, controlled, prospective trials are missing.

In this study, the effect of shock-waves on diabetic foot ulcer shall be assessed.

The study is composed of 5 groups of which 4 groups receive shock wave treatments (each with a different protocol). One group serves as an untreated control group. All groups get standardized wound treatment and wound dressing.

That shock-wave application protocol that shows the best results (rate of completely healed ulcer, most decrease of ulcer size) shall be tested in a further, sufficiently dimensioned, two-armed, randomized controlled trial (RCT).


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00954343
Study type Interventional
Source Technische Universität München
Contact
Status Withdrawn
Phase N/A
Start date August 2009

See also
  Status Clinical Trial Phase
Recruiting NCT04457752 - Evaluating the Efficacy of Dual Layer Amniotic Membrane (Artacent®) Phase 4
Terminated NCT02571738 - Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers Phase 3
Completed NCT00632008 - Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers Phase 3
Recruiting NCT00366132 - Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers Phase 2
Terminated NCT05276401 - Nu-3 Topical Gel for Treatment of Diabetic Foot Ulcer Phase 2
Completed NCT03282981 - Beta Adrenergic Antagonist for the Healing of Chronic DFU Phase 3
Completed NCT02098447 - Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds N/A
Recruiting NCT04962139 - Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers Phase 3